To deliver clinical information that saves lives and saves money, OBS Medical are working with some of the world’s leading healthcare organisations, hospital data service providers and medical device manufacturers.
Baxter – Hillrom – Welch Allyn
Baxter’s acquisition of Hillrom has formed one of the world’s leading medical technology companies, centered around a shared vision to transform healthcare.
In January 2020, Hillrom acquired Excel Medical Electronics, a clinical communications software company. Excel Medical expanded Hillrom’s digital health offerings with predictive analytics and software that assimilates real-time patient data.
Visensia® The Safety Index features in Excel Medicals next-generation clinical decision support solution – WAVE for advanced and early detection of patient deterioration in acute care settings.
WAVE is the only complete platform to move caregivers effortlessly from a reactive healthcare delivery system to a predictive one that is actionable and user-friendly.
External Website: EME – Excel Medical Electronics
- 8 January 2018 – Predictive Patient Surveillance System Receives FDA Clearance
- 9 June 2017 – AAMI 2017 Annual Conference
- 15 May 2017 – 13th International Conference On Rapid Response Systems and Medical Emergency Teams (ISRRS)
- 13 Dec 2021 – Hillrom is now part of Baxter
Therapeutic Monitoring Systems
Therapeutic Monitoring Systems (TMS) develops clinical decision support software for use in critical care medicine. TMS transforms the way patient monitoring is used and markedly improves patient care, by turning waveforms variability into clinical decision support software at the bedside of critically ill patients.
OBS Medical and TMS have partnered to provide a suite of complimentary AI driven technologies to enhance patient care.
- Extubation Advisor (EA) is the first of such technologies available to market within the European Economic Area (EEA) and UK.
Extubation Advisor (EA) is a new product designed to be used by clinicians caring for mechanically ventilated patients being considered for extubation in an ICU setting.
Using Respiratory Rate Variability (RRV) metrics during a Spontaneous Breathing Trial (SBT), EA will provide an estimate of the risk of extubation failure and associated confidence interval.
In addition, EA will provide a standardized performance and reporting of the SBT, used to assess a patient’s readiness for extubation. This combination of standardized SBT performance and reporting, along with optimal prediction of extubation outcomes, will aim to improve outcomes by decreasing the incidence of extubation failure and reduce costs by expediting extubation of low-risk patients, shortening ICU length of stay.
For more information, visit https://therapeuticmonitoring.com/extubation-advisor
External Website: Therapeutic Monitoring Systems
In the news:
Remote Patient Monitoring
Qardio is a health technology company that operates at the intersection of cardiology, remote monitoring, and medical SaaS. Qardio’s suite of remote monitoring solutions provide improved outcomes for care providers and their patients via improved workflows and diagnostic yields, reduced cost, and ease of use.
QardioMD+VSI is a remote monitoring solution that combines the data from Qardio’s range of award winning and medically accurate wearables, with the Visensia® predictive algorithm. This combination allows Clinicians to remotely review a patients’ vital signs in real time and to prioritise those patients according to the Visensia risk stratification algorithm – Visensia Safety Index (VSI).
For more information, visit www.getqardio.com/qardiomd-vsi/
External Website: QardioMD+VSI